{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:37Z","timestamp":1787021077515,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CannaMore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation, epithelial barrier disruption, and immune dysregulation. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, and sodium propionate (Na-P), a short-chain fatty acid, posses complementary anti-inflammatory and epithelial-protective properties. This study aimed to evaluate the safety and efficacy of a novel rectal enema formulation combining CBD and Na-P in a murine model of dextran sodium sulfate (DSS)-induced colitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Experimental colitis was induced in C57BL\/6 mice via 2.5% DSS administration for five days. Mice received one of 4 daily rectal treatments from day 4 to day 11: saline, hyaluronic acid (HA, vehicle), HA\u2009+\u2009CBD, HA\u2009+\u2009Na-P, or HA\u2009+\u2009CBD+Na-P. Clinical disease activity was monitored through the Disease Activity Index (DAI), body weight, colon length, and histopathological evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Colon length analysis demonstrated a 34.7% increase in length in the combination group versus saline control, significantly exceeding improvements observed with CBD or Na-P alone (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The combination treatment of CBD and Na-P led to a significant and sustained reduction in DAI scores compared to controls and monotherapies. Notably, the combination group exhibited a steeper improvement in DAI from day 6 onwards and showed superior outcomes on day 11 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.004 vs. HA). Body weight loss was markedly attenuated in the combination group, with statistical significance observed from day 6 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), while single-agent treatments exhibited only partial benefit. Histopathological scores were reduced in the combination group, accompanied by decreased neutrophilic infiltration and attenuation of mucosal damage, though statistical significance was not reached compared to monotherapies. Importantly, no hemorrhages or fibrin deposits were observed in any group, supporting the safety profile of the combination treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This preclinical study demonstrates that rectal administration of a CBD and Na-P enema exerts potential synergistic therapeutic effects in experimental UC, effectively reducing disease severity, preserving colon morphology, and mitigating histopathological damage. These findings support further clinical investigation of this novel dual-targeted approach for UC management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00400-4","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:49:18Z","timestamp":1774334958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel enema formulation containing cannabidiol and sodium propionate for ulcerative colitis: preclinical assessment in a murine model"],"prefix":"10.1186","volume":"8","author":[{"given":"Timna","family":"Naftali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Prutchi Sagiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"4","key":"400_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/00365521.2018.1447597","volume":"53","author":"B Ahluwalia","year":"2018","unstructured":"Ahluwalia B, Moraes L, Magnusson M, \u00d6hman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018;53(4):379\u201389.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"400_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Reviews Gastroenterol Hepatol. 2015;12(4):205\u201317.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"400_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"S Atalay","year":"2020","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidant and anti-inflammatory properties of Cannabidiol. Antioxid (Basel). 2020;9(1):21.","journal-title":"Antioxid (Basel)"},{"issue":"4","key":"400_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RHC, Crippa JAS, Zuardi AW. Safety and side effects of cannabidiol, a cannabis sativa constituent. Curr Drug Saf. 2011;6(4):237\u201349.","journal-title":"Curr Drug Saf"},{"issue":"16","key":"400_CR5","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.3390\/ijms241612580","volume":"24","author":"A Bilkei-Gorzo","year":"2023","unstructured":"Bilkei-Gorzo A, Albayram O, Michel K, Piyanova A, Vasas A, Kunstner A, et al. Molecular and cellular mechanisms of action of Cannabidiol. Int J Mol Sci. 2023;24(16):12580.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"400_CR6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","volume":"87","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, et al. Beneficial effect of the non-psychotropic plant cannabinoid Cannabidiol on experimental colitis. J Mol Med (Berl). 2009;87(11):1111\u201321.","journal-title":"J Mol Med (Berl)"},{"issue":"15","key":"400_CR7","first-page":"25","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing B, Aitken J, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104(15):25.","journal-title":"Curr Protoc Immunol"},{"issue":"5","key":"400_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/ibd\/izad312","volume":"30","author":"Y Chunhua","year":"2024","unstructured":"Chunhua Y, Didier M. Unveiling colitis: A journey through the dextran sodium Sulfate-induced model. Inflamm Bowel Dis. 2024;30(5):844\u201353.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"400_CR9","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7(8):4557\u201376.","journal-title":"Int J Clin Exp Pathol"},{"key":"400_CR10","doi-asserted-by":"publisher","first-page":"20190489","DOI":"10.1084\/jem.20190489","volume":"217","author":"JL Fachi","year":"2020","unstructured":"Fachi JL, S\u00e9cca C, Rodrigues PB, de Mato FCP, Di Luccia B, de Souza Felipe JS, et al. Acetate coordinates neutrophil and ILC3 responses against clostridioides difficile infection through FFAR2. J Exp Med. 2020;217:20190489.","journal-title":"J Exp Med"},{"issue":"5","key":"400_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1753-4887.2011.00388.x","volume":"69","author":"E Hosseini","year":"2011","unstructured":"Hosseini E, Grootaert C, Verstraete W, Van de Wiele T. Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev. 2011;69(5):245\u201358.","journal-title":"Nutr Rev"},{"issue":"4","key":"400_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ibd\/izy002","volume":"24","author":"PM Irving","year":"2018","unstructured":"Irving PM, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N, et al. A Randomized, Double-blind, Placebo-controlled, Parallel-group, pilot study of Cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflamm Bowel Dis. 2018;24(4):714\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"400_CR13","first-page":"1","volume":"26","author":"M Kim","year":"2017","unstructured":"Kim M, Kim H. The roles of Short-Chain fatty acids in gut health and immune regulation. Food Sci Biotechnol. 2017a;26(1):1\u20139.","journal-title":"Food Sci Biotechnol"},{"issue":"1","key":"400_CR14","first-page":"1","volume":"26","author":"MH Kim","year":"2017","unstructured":"Kim MH, Kim H. The roles of short-chain fatty acids in gut health and immune regulation. Food Sci Biotechnol. 2017b;26(1):1\u20139.","journal-title":"Food Sci Biotechnol"},{"issue":"3","key":"400_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","volume":"156","author":"C Ko","year":"2019","unstructured":"Ko C, Singh S, Feuerstein J, Falck-Ytter C, Falck-Ytter Y, Cross R. AGA clinical practice guidelines on the management of Mild-to-Moderate ulcerative colitis. Gastroenterology. 2019;156(3):748\u201364.","journal-title":"Gastroenterology"},{"key":"400_CR16","doi-asserted-by":"crossref","unstructured":"Malfait A, Gallily R, Sumariwalla P, Malik A, Andreakos E, Mechoulam R et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences. 2000; 97(17): 9561\u20139566.","DOI":"10.1073\/pnas.160105897"},{"issue":"3","key":"400_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"D Morrison","year":"2016","unstructured":"Morrison D, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189\u2013200.","journal-title":"Gut Microbes"},{"issue":"Suppl 1","key":"400_CR18","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.1093\/ecco-jcc\/jjx180.525","volume":"12","author":"TBLSLSBFLIHJKF Naftali","year":"2018","unstructured":"Naftali TBLSLSBFLIHJKF. Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC). J Crohns Colitis. 2018;12(Suppl 1):S306.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"400_CR19","doi-asserted-by":"publisher","first-page":"e0246871","DOI":"10.1371\/journal.pone.0246871","volume":"16","author":"T Naftali","year":"2021","unstructured":"Naftali T, Bar-Lev Schleider L, Scklerovsky Benjaminov F, Konikoff F, Matalon S, Ringel Y. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial. PLoS ONE. 2021;16(2):e0246871.","journal-title":"PLoS ONE"},{"issue":"5","key":"400_CR20","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(24)02327-8","volume":"166","author":"T Naftali","year":"2024","unstructured":"Naftali T, Stein A, Kyless H, Prutchi-Sagiv S. Safety, tolerability and efficacy of a novel enema formulation of Cannabidiol (CBD) and sodium propionate for the treatment for active ulcerative proctitis. Gastoenterology. 2024;166(5):S\u2013802.","journal-title":"Gastoenterology"},{"issue":"8","key":"400_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","volume":"20","author":"MF Neurath","year":"2019","unstructured":"Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20(8):970\u20139.","journal-title":"Nat Immunol"},{"key":"400_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324\u201338.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"400_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659\u201361.","journal-title":"FASEB J"},{"issue":"1","key":"400_CR24","first-page":"267","volume":"71","author":"R Shah","year":"2011","unstructured":"Shah R, Richardson P, Yu L, Willoughby CH, Elson CO, Washington MK, et al. Progression of adenomas to colonic carcinomas in mice is associated with altered expression of \u03b2-catenin and peroxisome proliferator-activated receptor-\u03b3. Cancer Res. 2011;71(1):267\u201377.","journal-title":"Cancer Res"},{"issue":"6145","key":"400_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"P Smith","year":"2013","unstructured":"Smith P, Howitt M, Panikov N, Michaud M, Gallini C, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569\u201373.","journal-title":"Science"},{"key":"400_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. TThe role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91\u2013119.","journal-title":"Adv Immunol"},{"issue":"10080","key":"400_CR28","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370.","journal-title":"Lancet"},{"issue":"10","key":"400_CR29","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.bbmt.2015.05.018","volume":"21","author":"M Yeshurun","year":"2015","unstructured":"Yeshurun M, Shpilberg O, Herscovici C, Shargian-Alon L, Dreyer J, Peck A, et al. Cannabidiol for the prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: results of a phase II study. Biol Blood Marrow Transpl. 2015;21(10):1770\u20135.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00400-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:45:03Z","timestamp":1781642703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00400-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00400-4","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with institutional and national guidelines for the care and use of laboratory animals. The study protocol was approved by The Council for Experiments on Animal Subjects, Ministry of Health, Israel (Approval No. NPC-Sc-IL-2108-121-4; approval date: August 8, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof Timna Naftali is an independent medical consultant for CannaMore Biotechs, Dr Sari Prutchi Sagiv is the CSO at CannaMore Biotechs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}